NOSAMAP vs DZolodronic Acid - What's the Bottom Line?

The NOSAMAP is obviously more potent as an anti-resopter, and it works better for hypercalcemia. It is one of the only drugs which is actually FDA approved for the treatment of malignant hyperCalcemia from cancer-related bone disease. The only word of caution is, you know, you can become hypocalcemic, so these patients need to be monitored carefully.